TW202385B - - Google Patents
Download PDFInfo
- Publication number
- TW202385B TW202385B TW081102738A TW81102738A TW202385B TW 202385 B TW202385 B TW 202385B TW 081102738 A TW081102738 A TW 081102738A TW 81102738 A TW81102738 A TW 81102738A TW 202385 B TW202385 B TW 202385B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- formula
- sister
- hepatitis
- patent application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919100039A GB9100039D0 (en) | 1991-01-03 | 1991-01-03 | Medicaments |
| GB919109913A GB9109913D0 (en) | 1991-05-07 | 1991-05-07 | Medicaments |
| EP92300056A EP0494119A1 (en) | 1991-01-03 | 1992-01-03 | Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202385B true TW202385B (cg-RX-API-DMAC7.html) | 1993-03-21 |
Family
ID=26298202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW081102738A TW202385B (cg-RX-API-DMAC7.html) | 1991-01-03 | 1992-04-09 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | USRE39155E1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP0565549B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2659863B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR0156747B1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE120644T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU660650B2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2254613A1 (cg-RX-API-DMAC7.html) |
| CY (1) | CY2047B1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69201948T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0565549T3 (cg-RX-API-DMAC7.html) |
| EE (1) | EE02995B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2070628T3 (cg-RX-API-DMAC7.html) |
| GE (1) | GEP19981482B (cg-RX-API-DMAC7.html) |
| GR (1) | GR3015694T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK159395A (cg-RX-API-DMAC7.html) |
| IE (1) | IE73642B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL100502A (cg-RX-API-DMAC7.html) |
| MD (1) | MD1224C2 (cg-RX-API-DMAC7.html) |
| NO (1) | NO180407C (cg-RX-API-DMAC7.html) |
| PH (1) | PH31397A (cg-RX-API-DMAC7.html) |
| TJ (1) | TJ249B (cg-RX-API-DMAC7.html) |
| TW (1) | TW202385B (cg-RX-API-DMAC7.html) |
| WO (1) | WO1992011852A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
| US6642245B1 (en) | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| US6703396B1 (en) | 1990-02-01 | 2004-03-09 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers |
| US6069252A (en) | 1990-02-01 | 2000-05-30 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
| US5925643A (en) * | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
| US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
| GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
| US6812233B1 (en) | 1991-03-06 | 2004-11-02 | Emory University | Therapeutic nucleosides |
| US5817667A (en) * | 1991-04-17 | 1998-10-06 | University Of Georgia Research Foudation | Compounds and methods for the treatment of cancer |
| GB9110874D0 (en) * | 1991-05-20 | 1991-07-10 | Iaf Biochem Int | Medicaments |
| US5932635A (en) * | 1991-07-30 | 1999-08-03 | Cytec Technology Corp. | Tackified prepreg systems |
| US20050192299A1 (en) * | 1992-04-16 | 2005-09-01 | Yung-Chi Cheng | Method of treating or preventing hepatitis B virus |
| GB9226927D0 (en) * | 1992-12-24 | 1993-02-17 | Iaf Biochem Int | Dideoxy nucleoside analogues |
| US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
| AU7954694A (en) * | 1993-09-10 | 1995-03-27 | Centre National De La Recherche Scientifique (Cnrs) | Nucleosides with anti-hepatitis b virus activity |
| US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
| IL113432A (en) * | 1994-04-23 | 2000-11-21 | Glaxo Group Ltd | Process for the diastereoselective synthesis of nucleoside analogues |
| IL115156A (en) | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
| JP3047045B2 (ja) * | 1994-10-22 | 2000-05-29 | チョン クン ダン コーポレーション | ヌクレオシド誘導体およびその製造方法 |
| US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
| US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
| US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
| US6689761B1 (en) | 1995-02-01 | 2004-02-10 | Merck & Co., Inc. | Combination therapy for HIV infection |
| ES2276404T3 (es) | 1995-06-07 | 2007-06-16 | Emory University | Nucleosidos con actividad antivirus de la hepatitis-b. |
| GB9517022D0 (en) * | 1995-08-19 | 1995-10-25 | Glaxo Group Ltd | Medicaments |
| GB9605293D0 (en) * | 1996-03-13 | 1996-05-15 | Glaxo Group Ltd | Medicaments |
| KR20000022226A (ko) | 1996-06-25 | 2000-04-25 | 그레이엄 브레레톤;레슬리 에드워즈 | Hiv 치료에 사용하기 위한 vx478, 지도부딘, ftc 및(또는) 3tc를 포함하는 배합물 |
| US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
| US6113920A (en) * | 1996-10-31 | 2000-09-05 | Glaxo Wellcome Inc. | Pharmaceutical compositions |
| US20030100532A1 (en) * | 1997-02-14 | 2003-05-29 | Gary S. Jacob | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
| CA2285577A1 (en) | 1997-04-07 | 1998-10-15 | Triangle Pharmaceuticals, Inc. | Compositions containing mkc-442 in combination with other antiviral agents |
| US6444652B1 (en) | 1998-08-10 | 2002-09-03 | Novirio Pharmaceuticals Limited | β-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
| US6395716B1 (en) | 1998-08-10 | 2002-05-28 | Novirio Pharmaceuticals Limited | β-L-2′-deoxy-nucleosides for the treatment of hepatitis B |
| IL142910A0 (en) * | 1998-11-02 | 2002-04-21 | Triangle Pharmaceuticals Inc | Combination therapy to treat hepatitis b virus |
| US6407077B1 (en) | 1998-11-05 | 2002-06-18 | Emory University | β-L nucleosides for the treatment of HIV infection |
| US6432966B2 (en) | 1999-10-29 | 2002-08-13 | Smithkline Beecham Corporation | Antiviral combinations |
| US6436948B1 (en) | 2000-03-03 | 2002-08-20 | University Of Georgia Research Foundation Inc. | Method for the treatment of psoriasis and genital warts |
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| US6787526B1 (en) | 2000-05-26 | 2004-09-07 | Idenix Pharmaceuticals, Inc. | Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides |
| PL359169A1 (en) | 2000-05-26 | 2004-08-23 | Idenix (Cayman) Limited | Methods and compositions for treating flaviviruses and pestiviruses |
| US6875751B2 (en) | 2000-06-15 | 2005-04-05 | Idenix Pharmaceuticals, Inc. | 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
| ATE383355T1 (de) | 2001-03-01 | 2008-01-15 | Abbott Lab | Polymorph und andere kristallinische formen von zusammen-ftc |
| US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
| KR20050035194A (ko) | 2002-06-28 | 2005-04-15 | 이데닉스 (케이만) 리미티드 | 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘 |
| CN101172993A (zh) | 2002-06-28 | 2008-05-07 | 埃迪尼克斯(开曼)有限公司 | 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷 |
| TWI244393B (en) | 2002-08-06 | 2005-12-01 | Idenix Pharmaceuticals Inc | Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
| SI1572095T1 (sl) | 2002-09-13 | 2015-12-31 | Novartis Ag | Beta-l-2'-deoksinukleozidi za uporabo pri zdravljenju odpornih sevov hbv |
| AU2003298658A1 (en) | 2002-11-15 | 2004-06-15 | Idenix (Cayman) Limited | 2'-branched nucleosides and flaviviridae mutation |
| US7598373B2 (en) | 2002-12-12 | 2009-10-06 | Idenix Pharmaceuticals, Inc. | Process for the production of 2-C-methyl-D-ribonolactone |
| US7781576B2 (en) | 2005-12-23 | 2010-08-24 | Idenix Pharmaceuticals, Inc. | Process for preparing a synthetic intermediate for preparation of branched nucleosides |
| WO2010137027A1 (en) | 2009-05-27 | 2010-12-02 | Hetero Research Foundation | Solid oral dosage forms of lamivudine |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT82580B (pt) * | 1985-05-15 | 1989-01-17 | Wellcome Found | Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem |
| CA1327000C (en) * | 1987-08-07 | 1994-02-15 | David L.J. Tyrrell | Antiviral therapy for hepatitis b |
| US5039667A (en) * | 1987-08-07 | 1991-08-13 | The Governors Of The University Of Alberta | Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides |
| US4997926A (en) * | 1987-11-18 | 1991-03-05 | Scripps Clinic And Research Foundation | Deaminase-stable anti-retroviral 2-halo-2',3'-dideoxy |
| US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| GB8815265D0 (en) * | 1988-06-27 | 1988-08-03 | Wellcome Found | Therapeutic nucleosides |
| JP2578501B2 (ja) * | 1989-03-03 | 1997-02-05 | キヤノン株式会社 | 電子写真用帯電部材 |
| NZ233197A (en) * | 1989-04-13 | 1991-11-26 | Richard Thomas Walker | Aromatically substituted nucleotide derivatives, intermediates therefor and pharmaceutical compositions |
| JPH04501854A (ja) * | 1989-05-15 | 1992-04-02 | アメリカ合衆国 | 肝炎の治療方法 |
| EP0472663A4 (en) * | 1989-05-15 | 1992-07-01 | Us Commerce | Method of treatment of hepatitis |
| ATE183508T1 (de) * | 1989-06-27 | 1999-09-15 | Wellcome Found | Therapeutische nukleoside |
| IE902574A1 (en) * | 1989-07-17 | 1991-02-27 | Univ Birmingham | Antiviral pyrimidine nucleosides |
| SE464168B (sv) * | 1989-07-19 | 1991-03-18 | Bo Fredrik Oeberg | Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt) |
| KR910007655A (ko) * | 1989-10-03 | 1991-05-30 | 엠. 피. 잭슨 | 치료용 뉴클레오시드 |
| IE74701B1 (en) * | 1989-10-04 | 1997-07-30 | Univ Birmingham | Further antiviral pyrimidine nucleosides |
| PT95516A (pt) * | 1989-10-06 | 1991-08-14 | Wellcome Found | Processo para a preparacao de derivados de 2',3'-didesoxi nucleosidos 6-substituidos |
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
| JP2960164B2 (ja) * | 1990-11-13 | 1999-10-06 | バイオケム ファーマ インコーポレイテッド | 抗ウイルス特性を有する置換1,3−オキサチオラン類および置換1,3−ジチオラン類 |
| IL100965A (en) * | 1991-02-22 | 1999-12-31 | Univ Emory | 2-Hydroxymethyl-5-(5-fluorocytosin-l-yl)-1,3-oxathiolane its resolution and pharmaceutical compositions containing it |
| CA2105486C (en) * | 1991-03-06 | 2003-10-28 | George Robert Painter Iii | Therapeutic nucleosides |
| GB9105899D0 (en) * | 1991-03-20 | 1991-05-08 | Wellcome Found | Therapeutic nucleosides |
| WO1992018517A1 (en) * | 1991-04-17 | 1992-10-29 | Yale University | Method of treating or preventing hepatitis b virus |
| GB9109506D0 (en) * | 1991-05-02 | 1991-06-26 | Wellcome Found | Therapeutic nucleosides |
| GB9110874D0 (en) * | 1991-05-20 | 1991-07-10 | Iaf Biochem Int | Medicaments |
-
1991
- 1991-12-25 IL IL10050291A patent/IL100502A/en not_active IP Right Cessation
-
1992
- 1992-01-02 IE IE920004A patent/IE73642B1/en not_active IP Right Cessation
- 1992-01-03 JP JP4501365A patent/JP2659863B2/ja not_active Expired - Lifetime
- 1992-01-03 CA CA002254613A patent/CA2254613A1/en not_active Abandoned
- 1992-01-03 AT AT92901354T patent/ATE120644T1/de not_active IP Right Cessation
- 1992-01-03 US US09/585,431 patent/USRE39155E1/en not_active Expired - Lifetime
- 1992-01-03 TJ TJ94000150A patent/TJ249B/xx unknown
- 1992-01-03 DE DE69201948T patent/DE69201948T2/de not_active Expired - Lifetime
- 1992-01-03 CA CA002100269A patent/CA2100269C/en not_active Expired - Lifetime
- 1992-01-03 GE GEAP19922644A patent/GEP19981482B/en unknown
- 1992-01-03 EP EP92901354A patent/EP0565549B1/en not_active Expired - Lifetime
- 1992-01-03 MD MD95-0086A patent/MD1224C2/ro unknown
- 1992-01-03 DK DK92901354.8T patent/DK0565549T3/da active
- 1992-01-03 PH PH43730A patent/PH31397A/en unknown
- 1992-01-03 WO PCT/CA1992/000001 patent/WO1992011852A1/en not_active Ceased
- 1992-01-03 EP EP92300056A patent/EP0494119A1/en active Pending
- 1992-01-03 AU AU11534/92A patent/AU660650B2/en not_active Expired
- 1992-01-03 ES ES92901354T patent/ES2070628T3/es not_active Expired - Lifetime
- 1992-01-03 US US08/084,222 patent/US5532246A/en not_active Ceased
- 1992-04-09 TW TW081102738A patent/TW202385B/zh active
-
1993
- 1993-07-02 KR KR1019930701998A patent/KR0156747B1/ko not_active Expired - Lifetime
- 1993-07-05 NO NO932442A patent/NO180407C/no not_active IP Right Cessation
-
1994
- 1994-10-20 EE EE9400302A patent/EE02995B1/xx unknown
-
1995
- 1995-04-06 GR GR940402226T patent/GR3015694T3/el unknown
- 1995-10-12 HK HK159395A patent/HK159395A/en not_active IP Right Cessation
-
1998
- 1998-04-30 CY CY9802047A patent/CY2047B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2659863B2 (ja) | B型肝炎の治療への1,3−オキサチオランヌクレオシドアナログの使用方法 | |
| CN111557939B (zh) | 法匹拉韦在制备用于治疗冠状病毒感染的药物中的应用 | |
| CN111494396B (zh) | 取代氨基丙酸酯类化合物在制备治疗SARS-CoV-2感染的药物中的应用 | |
| KR100542536B1 (ko) | 지도부딘,1592u89및3tc또는ftc의상승작용성복합제제 | |
| US20230219993A1 (en) | Antiviral application of nucleoside analog or combination formulation containing nucleoside analog | |
| RU2116789C1 (ru) | Способ ингибирования вирусных инфекций гепатита в | |
| CN101990434B (zh) | 用于治疗沙粒病毒感染的抗病毒药物 | |
| RS61064B1 (sr) | Modulatori proteina jezgra hepatitisa b | |
| BR112020018209A2 (pt) | Composições farmacêuticas, recipiente pressurizado, e, métodos para tratar ou prevenir uma infecção viral e para tratar ou prevenir um coronavírus humano, coronavírus sars, coronavírus mers, vírus da encefalite equina oriental, vírus da encefalite equina ocidental, vírus da encefalite equina venezuelana, vírus da chicungunha, vírus ross river, rsv, vírus influenza a, vírus influenza b, vírus tacaribe, vírus pichinde, vírus junin, vírus da febre lassa, vírus da cariomeningite linfocitária, vírus da febre rift valley, vírus punta toro, vírus lacrosse, vírus maporal, vírus heartland, e vírus da síndrome de trombocitopenia de febre severa, poliovírus, vírus de coxsackie, infecção de norovírus ou enterovírus em um paciente | |
| JP2818299B2 (ja) | ウイルス感染の治療におけるジデオキシヌクレオシドアナローグの使用 | |
| JPH11512083A (ja) | C型肝炎の治療における1,3−オキサチオランヌクレオシドアナログ | |
| JPH05202045A (ja) | 肝炎の処置に有用な1,3−オキサチオラン | |
| AU2017281531A1 (en) | Phosphoramidates for the treatment of hepatitis B virus | |
| JPH06506199A (ja) | 抗ウイルス性ヌクレオシドコンビネーション | |
| WO2022017304A1 (zh) | 大麻二酚在治疗冠状病毒感染中的应用 | |
| US20230077704A1 (en) | Application of nitazoxanide and active form thereof, tizoxanide, in treatment of sars-cov-2 infection | |
| WO2022017439A1 (zh) | 青蒿素类化合物在治疗冠状病毒感染方面的应用 | |
| US20230263748A1 (en) | Application of benflumetol and derivatives thereof in treatment of coronavirus infection | |
| US20190290673A1 (en) | Compositions and methods for the treatment of hbv infection | |
| US20250019392A2 (en) | Bicyclic heterocyclic compounds for prophylaxis andtreatment of viral infections | |
| JPH07508998A (ja) | 抗ウイルス剤の組み合わせ | |
| HK40029985B (en) | Application of favipiravir in manufacture of a medicament for treating coronavirus infection | |
| TWI230610B (en) | Dosage kits and pharmaceutical compositions for treating HIV infections | |
| US20220241241A1 (en) | Oxalamido-substituted tricyclic inhibitors of hepatitis b virus | |
| WO2000018383A2 (en) | Antiviral combinations comprising (s)-2- ethyl-7- fluoro-3- oxo-3,4- dihydro-2h- quinoxaline-1- carboxylic acid isopropyl ester |